Antiphospholipid syndrome
ICD-10 D68.61 is a billable code used to indicate a diagnosis of antiphospholipid syndrome.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPL) that lead to an increased risk of thrombosis and pregnancy-related complications. Patients with APS may experience recurrent venous or arterial thrombosis, which can manifest as deep vein thrombosis, pulmonary embolism, stroke, or myocardial infarction. Additionally, women with APS may face obstetric complications such as recurrent miscarriages, stillbirth, or preeclampsia. The syndrome is often associated with other autoimmune diseases, particularly systemic lupus erythematosus (SLE). Diagnosis typically involves laboratory tests to detect aPL, including lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Management of APS focuses on anticoagulation therapy to prevent thrombotic events, with options including warfarin and low molecular weight heparin. The complexity of APS arises from its variable clinical presentation, the need for careful monitoring of anticoagulation therapy, and the potential for overlapping conditions such as thrombocytopenia and other bleeding disorders.
Detailed history of autoimmune symptoms, laboratory test results, and treatment plans.
Diagnosis and management of APS in patients with SLE or other autoimmune disorders.
Ensure clear documentation of the relationship between APS and any coexisting conditions.
Comprehensive records of coagulation profiles, treatment regimens, and monitoring of anticoagulation therapy.
Management of thrombotic events in patients with APS.
Document any changes in anticoagulation therapy and patient response.
Used to monitor platelet levels in patients with APS.
Document the reason for the CBC and any relevant clinical findings.
Rheumatologists and hematologists should ensure that the CBC results are linked to the management of APS.
Common symptoms include recurrent thrombosis, pregnancy complications, and sometimes thrombocytopenia. Patients may also experience symptoms related to underlying autoimmune conditions.
